BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17934335)

  • 1. Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells.
    Sung YK; Park MK; Hong SH; Hwang SY; Kwack MH; Kim JC; Kim MK
    Exp Mol Med; 2007 Aug; 39(4):477-82. PubMed ID: 17934335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma.
    Sung YK; Hwang SY; Park MK; Bae HI; Kim WH; Kim JC; Kim M
    Cancer Sci; 2003 May; 94(5):421-4. PubMed ID: 12824887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of fatty acid-CoA ligase 4 on the growth of hepatic cancer cells.
    Hu C; Chen L; Jiang Y; Li Y; Wang S
    Cancer Biol Ther; 2008 Jan; 7(1):131-4. PubMed ID: 18059177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: roles of cyclic AMP and p38 mitogen-activated protein kinase.
    Liang YC; Wu CH; Chu JS; Wang CK; Hung LF; Wang YJ; Ho YS; Chang JG; Lin SY
    World J Gastroenterol; 2005 May; 11(17):2557-63. PubMed ID: 15849811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma.
    Cao Y; Dave KB; Doan TP; Prescott SM
    Cancer Res; 2001 Dec; 61(23):8429-34. PubMed ID: 11731423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of arachidonic acid metabolism act synergistically to signal apoptosis in neoplastic cells.
    Monjazeb AM; High KP; Koumenis C; Chilton FH
    Prostaglandins Leukot Essent Fatty Acids; 2005 Dec; 73(6):463-74. PubMed ID: 16169197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular unesterified arachidonic acid signals apoptosis.
    Cao Y; Pearman AT; Zimmerman GA; McIntyre TM; Prescott SM
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11280-5. PubMed ID: 11005842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and roles of fatty acid synthase in hepatocellular carcinoma.
    Hao Q; Li T; Zhang X; Gao P; Qiao P; Li S; Geng Z
    Oncol Rep; 2014 Dec; 32(6):2471-6. PubMed ID: 25231933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Growth inhibition of human hepatocellular carcinoma by miRNA-204 via down-regulation of Bcl-2 and Sirt1 expression].
    Li K; Xyu Q; Liu X; Liu Q; Wang M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):168-72. PubMed ID: 25652855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liver.
    Vessey DA; Kelley M; Warren RS
    J Biochem Mol Toxicol; 2004; 18(2):100-6. PubMed ID: 15122652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
    Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T
    Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells.
    Höpfner M; Huether A; Sutter AP; Baradari V; Schuppan D; Scherübl H
    Biochem Pharmacol; 2006 May; 71(10):1435-48. PubMed ID: 16530734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
    Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
    Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
    Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro.
    Chen YL; Yan MY; Chien SY; Kuo SJ; Chen DR; Cheng CY; Su CC
    Mol Med Rep; 2013 May; 7(5):1487-93. PubMed ID: 23525225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death.
    Uen YH; Ko PH; Yin PH; Liu TY; Chi CW; Lui WY
    Int J Oncol; 2008 Dec; 33(6):1263-70. PubMed ID: 19020760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
    Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
    Mashima T; Oh-hara T; Sato S; Mochizuki M; Sugimoto Y; Yamazaki K; Hamada J; Tada M; Moriuchi T; Ishikawa Y; Kato Y; Tomoda H; Yamori T; Tsuruo T
    J Natl Cancer Inst; 2005 May; 97(10):765-77. PubMed ID: 15900046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho GDP dissociation inhibitor beta promotes cell proliferation and invasion by modulating the AKT pathway in hepatocellular carcinoma.
    Fang Y; Yi J; Lizhi L; Qiucheng C
    DNA Cell Biol; 2014 Nov; 33(11):781-6. PubMed ID: 25180836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.